Scienture Holdings, Inc. · NASDAQ:SCNX
Scienture — TRxADE Group — Investor Presentation (April 2021)
20 slides from Scienture's investor presentation, Apr 21, 2021
Slide 1: Investor Presentation - April 2021
Investor Presentation - NASDAQ: MEDS April 2021
Slide 2: Safe Harbor Statement
Safe Harbor Statement The information set forth herein contains forward-looking statements. Forward-looking statements include all statements that do not relate solely to historical or current facts, including, but not limited to, statements regerding future operations, financial results, cash flows
Slide 3: About TRxADE Group, Inc.
About TRxADE Group, Inc. TRxADE Group, Inc. TRXADE is a technology-enabled health services platform company focused (NASDAQ: MEDS) on digitalizing the retail pharmacy experience by optimizing drug Share Price? $4.26 procurement, the prescription journey and patient engagement in the U.S. Market Capt
Slide 4: Divisions of TRxADE Group
Divisions of TRXADE Group Platform Company with Various B2B + B2C Subsidiaries 52<) TRADE MEDCHEKS (Health Passport) BONUM (TeleHealth) a) COMMUNITY SPECIALTY PHARMACY (Pharmacy) INTEGRAF PHARMA SOLUTIONS (Rx Distributor) “Innovation Lab” (Technology Bridge) 1) Pie slices not representative of reven
Slide 5: TRxADE Marketplace
TRxADE Marketplace Our B2B Pharmaceutical Supply Chain Platform U.S. Pharmaceutical Industry* *Projected $685B per year industry size by 2023 and growing; Over 65,000 pharmacy facilities * Approximately 9 out of 10 Americans live within 5 miles of a community pharmacy * Excluding several large natio
Slide 6: TRxADE Marketplace
TRxADE Marketplace Our B2B Pharmaceutical Supply Chain Platform Our Marketplace Solution * TRXADE’s exchange platform offers a clear and concise interface that allows registered independent pharmacies to analyze “up-to-the-minute” supply & pricing from multiple pharma suppliers * Economies of scale
Slide 7: Bonum Health
Bonum Health # )/ BONUM HEALTH Patient Centric Telehealth Services Access to Board-Certified Providers & Health Assessment Tools from Anywhere Individually or through an employer sponsored program, patients can access board-certified medical providers nationwide using the Bonum Health mobile app, we
Slide 8: Healthcare Infrastructure
Healthcare Infrastructure Pharmacy & Wholesale Divisions Broaden Capabilities PHARMA SO} Integra Pharma Solutions Integra Pharma Solutions is the pharmaceutical supplier of choice for healthcare organizations of all sizes. The Company’s expertise in the distribution of products extends to all health
Slide 9: MedCheks Digital Health Passport
MedCheks Digital Health Passport Secure Display of Vaccination & COVID-19 Test Result Status The MedCheks Health Passport, currently in development, will store an individual’s health records safely in one place leveraging state-of-the- art encryption & blockchain technology, allowing the holder to s
Slide 10: Tomorrow's Digital Health Services Opportunity
Tomorrow’s Digital Health Services Opportunity Current Pharmacy Services Landscape Non-Insurance based technology providers * GoodRx * RO * Hims * Phil New Age Digital Pharmacies * Amazon-PillPak * Alto Pharmacy * Capsule * Nimble * HealthWarehouse ° True Pill Logistic Providers * ScriptDrop * Uber
Slide 11: TRxADE's Opportunity
TRxADE’s Opportunity The Opportunity Digitally unify brick and mortar retail pharmacies to deliver exceptional patient-centric health services We believe the industry needs: A true partner with experience and resources to create complex bridges between fragmented healthcare services to drive coordin
Slide 12: TRxADE's Future Vision: A Digital Health Services Ecosystem
TRxADE’s Future Vision: A Digital Health Services Ecosystem* Goal to Create a Trusted Technology Platform Delivering Exceptional Patient Health Outcomes Telemedicine Telepharmacy Digital Health Passport Access to a licensed physician Access to a licensed network pharmacist | Comprehensive digital va
Slide 13: TRxADE Industry Comparable Companies
TRxADE Industry Comparable Companies? Valuation? Category: Prescription TRxADE $35M Secondary Marketplace Distribution (B2B) Amerisource (Good Neighbor Pharmacy) $21B Primary Supplier McKesson (Healthmart) $28B Primary Supplier Cardinal (Leader) $15B Primary Supplier Pharmacy Comps - Retail Distribu
Slide 14: Selected Financials
Selected Financials ——— * Rapid Growth: 130% YoY growth in FY2020 with strong sequential growth, recent revenue growth bolstered by wholesale transactions * High Margin: Revenue from transaction fees on marketplace platform (Credit Card/PayPal model) does not include the drugs value (over $100M annu
Slide 15: Management
Management Suren Ajjarapu, Chairman of the Board and Chief Executive Officer Mr. Ajjarapu has served as Chairman of the Board, Chief Executive Officer and Secretary since our acquisition of TRxADE Group, Inc., a Nevada corporation (“TRxADE Nevada”) (our predecessor company) on January 8, 2014, and a
Slide 16: Key Takeaways
Key Takeaways NASDAQ:MEDS TRxADE is a technology-enabled health services platform company focused on digitalizing Annual Revenue Growth the retail pharmacy experience by optimizing drug procurement, the prescription journey (USD $ in Thousands) and patient engagement in the U.S. $17,122 A Tech Focus
Slide 17: Investor Relations Contact
Investor Relations Contact Lucas A. Zimmerman Senior Vice President MZ North America Main: 949-259-4987 MEDS@mzgroup.us Wwww.mzgroup.us Contact Us TRxADE Group, Inc. 3840 Land O' Lakes Boulevard Land O'Lakes, FL 34639 (800) 261-0281 www.trxadegroup.com @TRADE www.trxade.com www.rxintegra.com www.bon
Slide 18: Appendix: Consolidated Balance Sheet
Appendix: Consolidated Balance Sheet Trxade Group, Inc. Consolidated Balance Sheets December 31, 2020 and 2019 December 31, December 31, 3020 Et) ia Current Assets Cash $ 5.919.578 $ 2,871,694 Accounts Receivable, net 805043 792.050 meee wast‘ S661 Prepaid Assets 1514882452 Other Receivables 1087675
Slide 19: Appendix: Consolidated Statements of Operations
Appendix: Consolidated Statements of Operations Trxade Group, Inc. Consolidated Statements of Operations Years Ended December 31, 2020 and 2019 Revenues, net Cost of Sales Gross Profit Operating Expenses Loss on write-off of software asset Loss on Impairment of Goodwill General and Administrative To
Slide 20: Appendix: Reconciliation of Net Income to Adj. EBITDA
Appendix: Reconciliation of Net Income to Adj. EBITDA? Reconciliation of Net Income (Loss) attributable to Trxade Group, Inc., to Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) and Adjusted EBITDA* For the three months ended December 31, Fiscal Year ended December 31, 2020 2